Synairgen plc (LON:SNG – Get Free Report) shares traded up 6.2% during mid-day trading on Tuesday . The stock traded as high as GBX 1.20 ($0.02) and last traded at GBX 0.90 ($0.01). 293,563 shares changed hands during trading, a decline of 80% from the average session volume of 1,453,790 shares. The stock had previously closed at GBX 0.85 ($0.01).
Synairgen Stock Up 6.2 %
The firm has a market cap of £8.83 million, a price-to-earnings ratio of -0.54 and a beta of -2.23. The company’s 50-day moving average price is GBX 1.94 and its 200-day moving average price is GBX 3.27.
Synairgen Company Profile
Synairgen is conducting a double blind, placebo-controlled clinical trial in COVID-19 patients (SG016).
Read More
- Five stocks we like better than Synairgen
- Health Care Stocks Explained: Why You Might Want to Invest
- Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- 2 Shorted Stocks Under Fire: Do Bulls or Bears Have It Right?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Is Intuitive Machines a Buy After Athena’s Disappointing Landing?
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.